Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1950 1
1951 4
1953 1
1954 1
1955 2
1956 1
1957 1
1958 1
1960 3
1961 6
1962 1
1963 4
1965 1
1967 4
1968 1
1969 1
1971 3
1972 1
1973 1
1974 1
1975 2
1977 1
1978 2
1984 1
1987 2
1988 1
1990 1
1991 2
1993 2
1994 5
1996 1
1997 4
1998 6
1999 2
2000 4
2001 4
2002 8
2003 11
2004 10
2005 6
2006 9
2007 14
2008 12
2009 12
2010 4
2011 6
2012 10
2013 16
2014 15
2015 14
2016 18
2017 18
2018 17
2019 17
2020 22
2021 19
2022 32
2023 34
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Results by year

Filters applied: . Clear all
Page 1
Functional Synthetic Biology.
Aldulijan I, Beal J, Billerbeck S, Bouffard J, Chambonnier G, Ntelkis N, Guerreiro I, Holub M, Ross P, Selvarajah V, Sprent N, Vidal G, Vignoni A. Aldulijan I, et al. Among authors: vidal g. Synth Biol (Oxf). 2023 Apr 8;8(1):ysad006. doi: 10.1093/synbio/ysad006. eCollection 2023. Synth Biol (Oxf). 2023. PMID: 37073284 Free PMC article. Review.
Symptomatic carotid webs require aggressive intervention.
Brinster CJ, O'Leary J, Hayson A, Steven A, Leithead C, Sternbergh WC 3rd, Money SR, Vidal G. Brinster CJ, et al. Among authors: vidal g. J Vasc Surg. 2024 Jan;79(1):62-70. doi: 10.1016/j.jvs.2023.09.002. Epub 2023 Sep 7. J Vasc Surg. 2024. PMID: 37683767
Selection of Biodegrading Phytosterol Strains.
Mondaca MA, Vidal M, Chamorro S, Vidal G. Mondaca MA, et al. Among authors: vidal g. Methods Mol Biol. 2023;2704:43-50. doi: 10.1007/978-1-0716-3385-4_3. Methods Mol Biol. 2023. PMID: 37642837
Ranking the risk of animal-to-human spillover for newly discovered viruses.
Grange ZL, Goldstein T, Johnson CK, Anthony S, Gilardi K, Daszak P, Olival KJ, O'Rourke T, Murray S, Olson SH, Togami E, Vidal G; Expert Panel; PREDICT Consortium; Mazet JAK; University of Edinburgh Epigroup members those who wish to remain anonymous. Grange ZL, et al. Among authors: vidal g. Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):e2002324118. doi: 10.1073/pnas.2002324118. Proc Natl Acad Sci U S A. 2021. PMID: 33822740 Free PMC article.
Molecular characterization of ESR1 variants in breast cancer.
Heeke AL, Elliott A, Feldman R, O'Connor HF, Pohlmann PR, Lynce F, Swain SM, Nunes MR, Magee D, Oberley MJ, Swenson J, Vidal G, Isaacs C, Schwartzberg L, Korn WM, Tan AR. Heeke AL, et al. Among authors: vidal g. Breast Cancer Res Treat. 2022 Nov;196(2):279-289. doi: 10.1007/s10549-022-06740-y. Epub 2022 Sep 20. Breast Cancer Res Treat. 2022. PMID: 36125660
Reducing Calf Mortality in Ethiopia.
Wong JT, Lane JK, Allan FK, Vidal G, Vance C, Donadeu M, Jackson W, Nwankpa V, Abera S, Mekonnen GA, Kebede N, Admassu B, Amssalu K, Lemma A, Fentie T, Smith W, Peters AR. Wong JT, et al. Among authors: vidal g. Animals (Basel). 2022 Aug 19;12(16):2126. doi: 10.3390/ani12162126. Animals (Basel). 2022. PMID: 36009716 Free PMC article.
Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study).
Napoléon B, Lisotti A, Caillol F, Gasmi M, Ah-Soune P, Belle A, Charachon A, Cholet F, Eyraud PY, Grandval P, Gonzalez JM, Habersetzer F, Koch S, Le Rhun M, Mangialavori L, Musquer N, Palazzo M, Poincloux L, Privat J, Sportes A, Stouvenot M, Subtil C, Thomassin L, Vanbiervliet G, Vidal G, Vuitton L, Giovannini M, Barthet M. Napoléon B, et al. Among authors: vidal g. Gastrointest Endosc. 2023 Sep;98(3):392-399.e1. doi: 10.1016/j.gie.2023.04.003. Epub 2023 Apr 12. Gastrointest Endosc. 2023. PMID: 37059368
Lasofoxifene versus fulvestrant for ER+/HER2- metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial.
Goetz MP, Bagegni NA, Batist G, Brufsky A, Cristofanilli MA, Damodaran S, Daniel BR, Fleming GF, Gradishar WJ, Graff SL, Grosse Perdekamp MT, Hamilton E, Lavasani S, Moreno-Aspitia A, O'Connor T, Pluard TJ, Rugo HS, Sammons SL, Schwartzberg LS, Stover DG, Vidal GA, Wang G, Warner E, Yerushalmi R, Plourde PV, Portman DJ, Gal-Yam EN. Goetz MP, et al. Among authors: vidal ga. Ann Oncol. 2023 Dec;34(12):1141-1151. doi: 10.1016/j.annonc.2023.09.3104. Ann Oncol. 2023. PMID: 38072514 Free article. Clinical Trial.
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.
Schmid P, Turner NC, Barrios CH, Isakoff SJ, Kim SB, Sablin MP, Saji S, Savas P, Vidal GA, Oliveira M, O'Shaughnessy J, Italiano A, Espinosa E, Boni V, White S, Rojas B, Freitas-Junior R, Chae Y, Bondarenko I, Lee J, Torres Mattos C, Martinez Rodriguez JL, Lam LH, Jones S, Reilly SJ, Huang X, Shah K, Dent R. Schmid P, et al. Among authors: vidal ga. Clin Cancer Res. 2024 Feb 16;30(4):767-778. doi: 10.1158/1078-0432.CCR-23-2084. Clin Cancer Res. 2024. PMID: 38060199 Free PMC article. Clinical Trial.
381 results